Site Search
Search Results
Prescription Drug Affordability in Michigan
ACS CAN supports legislation that restricts the use of so-called copay accumulator adjustments in health insurance plans. We advocate for policies that ensure third party prescription drug copay assistance is counted toward patients’ out-of-pocket cost obligations. Prescription drug affordability safegaurds that patients and their families can care for themselves while reducing the burden of toxic medical debt. Michigan cancer patients and others rely on prescription drug copay ... two cancer survivors struggles without copay accumulators: Video of krin_gary_westby_wisconsin Video of acs_can_barriers_to_care_julie_turner_fc2 Read about the impact of copay accumulators found through our Survivor Views survey: In March & April of 2024, ACS CAN ...
Top N.C. Cancer Experts to Discuss Critical Need of Increasing Patient Access to Clinical Trials at Event Hosted by Nation’s Leading Cancer Advocacy Group
... 60,000 people in North Carolina will be diagnosed with cancer and more than 20,000 will die from the disease. WHAT: ‘Increasing Access to Care Through Clinical Trials: Potential Problems and Promising Practices’ The event will bring together key thought leaders and subject matter ... research, University of North Carolina Lineberger Comprehensive Clinical Cancer Center. - Dr. Karen Winkfield, director, Office of Cancer Health Equity & associate director for Community Outreach & Engagement, associate professor of radiation oncology, Wake Forest Baptist Health Comprehensive Cancer Center. - Patrick Nealon, executive vice president and general manager of oncology, Syneos Health. - Rep. Wayne ...
House Passes Bill that Undermines Decades of Success in Hawaii’s Tobacco Prevention and Control Efforts
... for good. At this critical moment, we should be doing everything to keep our communities healthy and safe—which means building strong public health infrastructure including protecting funding for comprehensive tobacco control programs. As we face an epidemic of youth e-cigarette use with ... "Without a reliable source of funding for tobacco prevention, Hawaii could see more youth using tobacco products, more lives lost and greater health care costs. ACS CAN urges the legislature to protect this critical funding to reduce the devastating burden of tobacco use on our communities and ...
Statement on the Death of Congressman Donald McEachin & Status of Virginians’ Access to Colorectal Cancer Screening
... our sincere condolences to Rep. McEachin’s wife and three daughters. “Throughout his time in Congress, Rep. McEachin was a champion of many health-related issues, including those involving clean air and access to care. We celebrate the Representative’s passion for Virginians’ health and safety, which led to his critical support for the Inflation Reduction Act, amongst other legislative efforts. “A cancer diagnosis is ...
New Jersey Expands Access to Preventative Colorectal Cancer Screenings
... a follow-up colonoscopy, presenting a barrier that inhibits the completion of the colorectal cancer screening process. This new law will require health insurers to cover colorectal cancer screenings recommended by the United States Preventive Services Task Force and eliminate cost-sharing ... and Governor Murphy should be incredibly proud of this legislation. It represents a huge step toward dismantling disparities and improving health outcomes for all New Jersey residents. ACS CAN applauds our state leaders and various stakeholders for prioritizing New Jerseyans’ access to critical care.” ACS CAN thanks Assemblymembers Benson, Stanley and Conaway and Senators Gopal and Greenstein for their leadership on this critical ...
2023 California Legislative Policy Roundtable
... Cancer Registry, the Regional Registries, and the roles they play in fighting cancer. Panelists will include members of the Legislature, public health advocates, and researchers who will demonstrate how they use the Registry to fight cancer. We will also honor State Senator Anthony J. Portantino (CA – SD25) for the passage of SB 987 - The California Cancer Care Equity Act which improves cancer care access, cancer survival, and patient experience by enhancing Medi-Cal patient access to necessary ... We invite you to be part of a group of sustaining supporters enabling ACS CAN’s work to catalyze discovery, accelerate cures, and improve health equity. With your help, our advocacy will not stop. Join us and together we can save lives and lead the fight for a world without cancer. To ...
Cancer Patients and Survivors Rally at the Statehouse
... They let their lawmakers know that Indiana can and must do better to prevent cancer and reduce suffering and death by improving access to care and reducing tobacco use. Advocates asked lawmakers to support legislation that would improve access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Biomarker testing has given me better, more ...
Coalition Requests Federal Taskforce Reconsider Colorectal Screening Guidelines
Washington, D.C. – Twenty-two public health and patient advocacy groups submitted a letter to the United States Preventive Services Task Force (USPSTF) today requesting it reconsider ... Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), follows: “ACS CAN is pleased to join the coalition of public health and patient advocacy groups respectfully requesting USPSTF reconsider its 2016 colorectal cancer screening recommendation. USPSTF has a ... the Task Force will take this new information into account as we work to give Americans evidence-based, age-appropriate access to preventive care services. “As the advocacy affiliate of the American Cancer Society, ACS CAN has aggressively worked to notify state and federal ...
Governor Signs Bill Increasing Access to Cancer Screening for High-Risk Delawareans
... men. The bill eliminates costs for certain patients to get these lifesaving screenings, thus reducing barriers and increasing access to care for men over 40 with certain risk factors. It’s estimated that over 1,300 Delawareans will receive a prostate cancer diagnosis in ... that the legislation received. “Thank you, Governor Carney and the Delaware legislature for making this bold move to prioritize men’s health,” said Ali Manson, ZERO Prostate Cancer’s Vice President of Government Relations & Advocacy. “Delaware is now one of only eight states ... barriers to screenings for men at the highest risk. Together, we are paving the way for other states to make this kind of investment in men’s health.” ### About ACS CAN The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the ...
Short-Term Limited Duration Plans
In 2018, the Department of Health and Human Services (HHS) issued a rule that could disrupt the health insurance market by extending for up to three years "short-term" policies that lack Affordable Care Act-guaranteed benefits. The rule took effect in early October of 2018, and significantly extended the amount of time permitted for ...
Type
- Action (16) Apply Action filter
- Basic page (219) Apply Basic page filter
- Blog Post (142) Apply Blog Post filter
- Event (167) Apply Event filter
- Landing Page (4) Apply Landing Page filter
- Press Release (2030) Apply Press Release filter
- Resource (101) Apply Resource filter
- State Priority (180) Apply State Priority filter
- Update (1157) Apply Update filter
Priority Issue
State
- National (459) Apply National filter
- Maine (216) Apply Maine filter
- Massachusetts (203) Apply Massachusetts filter
- New York (197) Apply New York filter
- Vermont (184) Apply Vermont filter
- New Jersey (94) Apply New Jersey filter
- Ohio (76) Apply Ohio filter
- Connecticut (75) Apply Connecticut filter
- California (74) Apply California filter
- Maryland (71) Apply Maryland filter
- North Carolina (67) Apply North Carolina filter
- Pennsylvania (66) Apply Pennsylvania filter
- Florida (59) Apply Florida filter
- Georgia (53) Apply Georgia filter
- Missouri (53) Apply Missouri filter
- Kentucky (49) Apply Kentucky filter
- Montana (47) Apply Montana filter
- Michigan (44) Apply Michigan filter
- Oklahoma (43) Apply Oklahoma filter
- Texas (43) Apply Texas filter
- Alabama (42) Apply Alabama filter
- Illinois (42) Apply Illinois filter
- Kansas (42) Apply Kansas filter
- Wisconsin (42) Apply Wisconsin filter
- Mississippi (41) Apply Mississippi filter
- South Carolina (41) Apply South Carolina filter
- West Virginia (41) Apply West Virginia filter
- Indiana (40) Apply Indiana filter
- South Dakota (39) Apply South Dakota filter
- Tennessee (39) Apply Tennessee filter
- Minnesota (37) Apply Minnesota filter
- Idaho (36) Apply Idaho filter
- Colorado (35) Apply Colorado filter
- Wyoming (35) Apply Wyoming filter
- Virginia (34) Apply Virginia filter
- Oregon (32) Apply Oregon filter
- Arizona (31) Apply Arizona filter
- New Mexico (31) Apply New Mexico filter
- Louisiana (29) Apply Louisiana filter
- Arkansas (28) Apply Arkansas filter
- Rhode Island (25) Apply Rhode Island filter
- Washington (25) Apply Washington filter
- New Hampshire (23) Apply New Hampshire filter
- Nevada (22) Apply Nevada filter
- Iowa (20) Apply Iowa filter
- Nebraska (20) Apply Nebraska filter
- North Dakota (20) Apply North Dakota filter
- Utah (20) Apply Utah filter
- Hawaii (18) Apply Hawaii filter
- Delaware (17) Apply Delaware filter
Policy Issue
- Access to Health Care (28) Apply Access to Health Care filter
- Prevention and Early Detection (11) Apply Prevention and Early Detection filter
- Health Equity (10) Apply Health Equity filter
- Patient Quality of Life (10) Apply Patient Quality of Life filter
- Research, Funding and Drug Development (4) Apply Research, Funding and Drug Development filter